[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-365590-105":3,"detail-sidebar-cat-0-en-105":81,"doc-detail-365590-en":130},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":74,"head_meta":76,"extra_data":78,"updated_unix":80},105,"en","role-of-cdh1-gene-variants-and-e-cadherin-localization-in-gastric-mucosal-cancerization","Role of CDH1 gene variants and E-cadherin localization in gastric mucosal cancerization","","Study evaluates how CDH1 gene single nucleotide polymorphisms, CDH1 mRNA transcription, and E-cadherin protein localization contribute to Helicobacter pylori–associated gastric mucosal carcinogenesis. Gastric mucosal samples were assessed by histopathology and Hp detection, while rs16260 genotyping was performed by sequencing and mRNA quantification by real-time PCR. E-cadherin localization was measured using Elivision™ Plus and analyzed with SPSS 25.0. Findings show no significant rs16260 genotype differences, but increased CDH1 transcription in gastric cancer and altered membrane-to-cytoplasmic E-cadherin with lesion severity.",{"@graph":14,"@context":73},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/role-of-cdh1-gene-variants-and-e-cadherin-localization-in-gastric-mucosal-cancerization/365590/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/role-of-cdh1-gene-variants-and-e-cadherin-localization-in-gastric-mucosal-cancerization/365590.png","ImageObject",300,407,{"name":42,"@type":43},"Sophia Brooks","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-11-15","2026-09-23",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",10,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69],{"name":60,"@type":61,"acceptedAnswer":62},"Did CDH1 rs16260 genotypes differ across gastric pathology groups?","Question",{"text":63,"@type":64},"No significant differences were found in CDH1 rs16260 genotypes among the categorized gastric mucosal pathology groups.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"How were CDH1 mRNA levels associated with gastric cancer development?",{"text":68,"@type":64},"CDH1 transcription was higher in gastric cancer compared with normal and premalignant lesion groups, and regression analysis suggested elevated CDH1 mRNA increased gastric cancer risk.",{"name":70,"@type":61,"acceptedAnswer":71},"What E-cadherin localization changes were observed with increasing lesion severity?",{"text":72,"@type":64},"Localization analysis showed decreased membrane-bound E-cadherin with increased cytoplasmic expression as lesion severity increased, and cytoplasmic ectopic expression was linked to higher risk of precancerous lesions and gastric cancer.","https://schema.org",{"og:url":32,"og:type":75,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":77,"canonical":32},"index,follow",{"doc_id":79,"site_id":7},365590,1790795655,{"code":4,"msg":82,"data":83},"success",[84,88,92,96,101,106,111,115,120,123,126],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":85,"show_sort_weight":86,"slug":87},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":89,"show_sort_weight":90,"slug":91},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":93,"show_sort_weight":94,"slug":95},"Exam",70,"exam",{"id":97,"doc_module":4,"doc_module_name":25,"category_name":98,"show_sort_weight":99,"slug":100},5,"Comic",60,"comic",{"id":102,"doc_module":4,"doc_module_name":25,"category_name":103,"show_sort_weight":104,"slug":105},6,"Technology",50,"technology",{"id":107,"doc_module":4,"doc_module_name":25,"category_name":108,"show_sort_weight":109,"slug":110},7,"Healthcare",40,"healthcare",{"id":112,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":113,"slug":114},8,30,"research-report",{"id":116,"doc_module":4,"doc_module_name":25,"category_name":117,"show_sort_weight":118,"slug":119},9,"Religion & Spirituality",20,"religion-spirituality",{"id":118,"doc_module":4,"doc_module_name":25,"category_name":121,"show_sort_weight":118,"slug":122},"World Cup","world-cup",{"id":55,"doc_module":4,"doc_module_name":25,"category_name":124,"show_sort_weight":55,"slug":125},"Lifestyle","lifestyle",{"id":127,"doc_module":4,"doc_module_name":25,"category_name":128,"show_sort_weight":97,"slug":129},19,"General","general",{"code":4,"msg":82,"data":131},{"doc_id":79,"user_id":132,"nickname":42,"user_avatar":133,"doc_module":4,"category_id":112,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":139,"language":140,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":12,"update_tm":144,"read_time":145,"preview_page_count":33,"preview_urls":146},962084925636,"https://ap-avatar.wpscdn.com/davatar_994ba38a5ba835b3df7d355c54d3ed8d","TYPE Original Research PUBLISHED 09 May 2025  \nDOI 10.3389/fonc.2025.1590680  \nOPEN ACCESS  \nEDITED BY  \nLuca Saragoni,  \nSanta Maria delle Croci Hospital, Italy  \nREVIEWED BY  \nJunji Itou,  \nNational Cerebral and Cardiovascular Center, Japan  \nHang Yin,  \nUniversity of Georgia, United States  \n*CORRESPONDENCE  \nLing Hu  \n [drhuling@163.com](drhuling@163.com)  \nRECEIVED 10 March 2025  \nACCEPTED 16 April 2025  \nPUBLISHED 09 May 2025  \nCITATION  \nWu Y, Zhang Y, Dai Y, Luo Q, Lan S, Chen X, Chen W, Li R and Hu L (2025) Role of CDH1 gene variants and E-cadherin localization in gastric mucosal cancerization.  \nFront. Oncol. 15:1590680 .  \ndoi: 10.3389/fonc.2025.1590680  \nCOPYRIGHT  \n© 2025 Wu, Zhang, Dai, Luo, Lan, Chen, Chen, Li and Hu. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY) . The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.  \nRole of CDH1 gene variants and E-cadherin localization in gastric mucosal cancerization  \nYunbo Wu 1, Yunzhan Zhang 1, Yunkai Dai 1, Qi Luo 2, Shaoyang Lan 2, Xu Chen 2, Weijing Chen 1, Ruliu Li 1 and Ling Hu 1*  \n1 Institute of Gastroenterology, Science and Technology Innovation Center, Guangzhou University of Chinese Medicine, Guangzhou, China, 2Gastroenterology Department, First Afﬁliated Hospital of Guangzhou University of Chinese Medicine, Guangzhou, China  \nBackground: This study investigates the role of CDH1 gene single nucleotide polymorphisms (SNPs), mRNA transcription levels, and E-cadherin protein localization in Helicobacter pylori (Hp)-associated gastric diseases and their contribution to gastric mucosal carcinogenesis.  \nMethods: Gastric mucosal samples were analyzed for histopathology (Hematoxylin-Eosin staining) and Hp detection (rapid urease test, Giemsa staining) . SNPs at the CDH1 gene rs16260 locus were identiﬁed via sequencing, mRNA levels were quantiﬁed by real-time PCR, and E-cadherin localization was assessed using Elivision™ Plus. Statistical analyses were performed with SPSS 25 .0.  \nResults: Participants were grouped by gastric mucosal pathology: normal (NOR), gastric inﬂammation (GI), gastric atrophy (GA), gastric premalignant lesion (GPL), severe dysplasia (GSD), and gastric cancer (GC) . No signiﬁcant differences were found in CDH1 rs16260 genotypes. However, CDH1 transcription was higher in GC compared to NOR and GPL groups. Intestinal metaplasia showed lower CDH1 mRNA levels. E-cadherin expression was higher in GSD and GC compared to other groups. Localization analysis revealed decreased membrane-bound Ecadherin with increased cytoplasmic expression as lesion severity increased. Quantitative analysis showed higher E-cadherin expression in GA than other groups, indicating an initial rise followed by a decline in malignancy. Regression analysis suggested that elevated CDH1 mRNA increased gastric cancer risk, while E-cadherin cytoplasmic ectopic expression heightened the risk of precancerous lesions and gastric cancer.  \nConclusion: The A allele of the CDH1 gene rs16260 locus show no effect in gastric mucosal pathological evolution, while the elevated mRNA transcription levels potentially increasing the risk of gastric cancer. The loss and ectopic expression of E-cadherin may be signiﬁcant risk factors for malignant transformation in the gastric mucosa.  \nKEYWORDS  \nE-caderin, CDH1, gastric cancer, SNP, Helicobacer pylori  \nFrontiers in Oncology 01 [frontiersin.org](frontiersin.org)  \n1 Introduction  \nGastric cancer (GC) is one of the most prevalent cancers globally, ranking ﬁfth in incidence and fourth in mortality among all cancers, posing a signiﬁcant threat to human health (1) . The development of GC results from the combi","cbCaimhB1ufFpYve","https://ap.wps.com/l/cbCaimhB1ufFpYve","pdf",4625970,11,"English","# 1 Introduction\n## Background and context\n# Methods\n## Study design and sample analyses\n## Genotyping and mRNA quantification\n## E-cadherin localization assessment\n# Results\n## CDH1 genotypes and transcription patterns\n## E-cadherin expression and localization changes\n## Regression analyses of risk associations\n# Conclusion","[{\"question\":\"Did CDH1 rs16260 genotypes differ across gastric pathology groups?\",\"answer\":\"No significant differences were found in CDH1 rs16260 genotypes among the categorized gastric mucosal pathology groups.\"},{\"question\":\"How were CDH1 mRNA levels associated with gastric cancer development?\",\"answer\":\"CDH1 transcription was higher in gastric cancer compared with normal and premalignant lesion groups, and regression analysis suggested elevated CDH1 mRNA increased gastric cancer risk.\"},{\"question\":\"What E-cadherin localization changes were observed with increasing lesion severity?\",\"answer\":\"Localization analysis showed decreased membrane-bound E-cadherin with increased cytoplasmic expression as lesion severity increased, and cytoplasmic ectopic expression was linked to higher risk of precancerous lesions and gastric cancer.\"}]","Role of CDH1 gene variants and E-cadherin localization in gastric mucosal cancerization | PDF",1790161382,28,[147,151,155,159],{"page_no":22,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/45d1dc0f0f28e61c4927d36f7909dacf.webp",983,1389,{"page_no":26,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/b3a2b5c15ee9aec8aafbfe4451a92f9a.webp",982,1388,{"page_no":30,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/6f9bcc7c494ee1a02bbef919d8162d19.webp",981,1386,{"page_no":33,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/9afcb0229d701e01214d19ae280908db.webp",980,1385]